Physician profile
Scott Doherty
NPI 1730108093
$460.69
in general payments reported to CMS, 2019-2025
7 companies · $28.26 in 2025
The $28.26 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $90.65 · 2020: $99.73 · 2022: $117 · 2024: $125 · 2025: $28.26.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $153.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $153.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $242.05 | 2022-2024 | Nuzyra |
| Amniox Medical, INC. | $99.73 | 2020 | |
| Horizon Therapeutics Plc | $30.59 | 2019 | |
| Shire North American Group INC | $30.00 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $28.26 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.05 | 2019 | |
| Hikma Pharmaceuticals USA | $12.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Doherty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.